All News about Exelixis Inc
![](https://cdn.benzinga.com/files/images/story/2012/cells-gdd37bc5d2_1920_16.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3838.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220314005623/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_1520.jpeg?width=1200&height=800&fit=crop)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cms.zerohedge.com/s3/files/inline-images/ES%202022-02-18_7-24-37.jpg?itok=W6DtXQUc)
Via Talk Markets
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_1579.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220217005137/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/ep_us_feature_image_755.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3509.png)
![](https://mms.businesswire.com/media/20220214005475/en/785869/5/BMS_Exelixis.jpg)
![](https://mms.businesswire.com/media/20220203005765/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://mms.businesswire.com/media/20220202005730/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://mms.businesswire.com/media/20220118006159/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://www.investors.com/wp-content/uploads/2021/03/Stock-DrugsPills-14-adobe.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/peek_into_the_marketnew_341.png)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://mms.businesswire.com/media/20220109005045/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://mms.businesswire.com/media/20220106005219/en/821218/4/logo_228x70px-1.jpg)
![](https://mms.businesswire.com/media/20220104005887/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20220104005660/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://mms.businesswire.com/media/20220104005214/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://investorplace.com/wp-content/uploads/2020/10/cheap-stocks.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_396.jpg)
![](https://mms.businesswire.com/media/20211217005072/en/610803/5/exelixis_id_rgb_2c.jpg)
Exelixis Elects Jacqueline Wright to Its Board of Directors
December 17, 2021
From Exelixis, Inc.
Via Business Wire
![](https://talkmarkets.com/contributor/mirjana-mishevska/user_content/ckimages/orig_annie-spratt-hwjsonawtqs-unsplash.jpg)
Uncertain Times
December 15, 2021
Via Talk Markets
![](https://mms.businesswire.com/media/20211214006098/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://mms.businesswire.com/media/20211120005130/en/611316/5/Exelixis_Logo_JPG.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.